KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Non-cash Items (2020 - 2022)

Historic Non-cash Items for GoodRx Holdings (GDRX) over the last 3 years, with Q4 2022 value amounting to $182.6 million.

  • GoodRx Holdings' Non-cash Items fell 4659.71% to $182.6 million in Q4 2022 from the same period last year, while for Dec 2022 it was $182.6 million, marking a year-over-year decrease of 4659.71%. This contributed to the annual value of $182.6 million for FY2022, which is 4659.71% down from last year.
  • Latest data reveals that GoodRx Holdings reported Non-cash Items of $182.6 million as of Q4 2022, which was down 4659.71% from $204.6 million recorded in Q3 2022.
  • In the past 5 years, GoodRx Holdings' Non-cash Items registered a high of $1.2 billion during Q3 2020, and its lowest value of $165.3 million during Q1 2022.
  • Moreover, its 3-year median value for Non-cash Items was $427.7 million (2021), whereas its average is $471.8 million.
  • Within the past 5 years, the most significant YoY rise in GoodRx Holdings' Non-cash Items was 4659.71% (2022), while the steepest drop was 7570.9% (2022).
  • GoodRx Holdings' Non-cash Items (Quarter) stood at $734.6 million in 2020, then plummeted by 53.45% to $341.9 million in 2021, then crashed by 46.6% to $182.6 million in 2022.
  • Its Non-cash Items stands at $182.6 million for Q4 2022, versus $204.6 million for Q3 2022 and $194.5 million for Q2 2022.